Heart Disease News and Research

Latest Heart Disease News and Research

Stroke patients with PTSD less likely to adhere to treatment regimens

A new survey of stroke survivors has shown that those with post-traumatic stress disorder (PTSD) are less likely to adhere to treatment regimens that reduce the risk of an additional stroke. Researchers found that 65 percent of stroke survivors with PTSD failed to adhere to treatment, compared with 33 percent of those without PTSD.

18 Jan 2013

nContact receives FDA clearance for EPi-Sense cardiac ablation device

nContact, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's modifications to its VisiTrax cardiac ablation device, EPi-Sense, now with embedded sensing capability.

18 Jan 2013

Octapharma receives FDA approval for Octaplas to treat blood clotting disorders

The U.S. Food and Drug Administration today approved Octaplas, a pooled plasma (human) blood product for the replacement of clotting proteins (coagulation factors) in certain medical conditions where patients have insufficient levels.

18 Jan 2013

Atrial fibrillation increases risk of kidney failure in people with CKD

Many people who suffer from chronic kidney disease progressively lose their kidney function over time and eventually develop a condition called end-stage renal disease - the complete failure of the kidneys - placing them in need of lifelong dialysis or a kidney transplant.

18 Jan 2013

Prevention opportunity for postoperative cardiac arrest

Postoperative complications occur in more than three-quarters of patients who have a cardiac arrest, shows research that suggests an opportunity for intervention.

17 Jan 2013

Dentate gyrus, fimbria volumes reduced in bipolar II disorder

Results from a Norwegian study suggest that the dentate gyrus and fimbria may play an important role in the pathophysiology of bipolar II disorder.

17 Jan 2013

Potential stem cell therapy for Duchenne’s

Researchers have found that injecting aorta-derived stem cells into the hearts of dystrophin-deficient mice prevents the onset of dilated cardiomyopathy, raising hopes of a potential new treatment approach to prevent or reverse the condition in human Duchenne muscular dystrophy.

17 Jan 2013

Miscarriage and molecular signals: an interview with Prof Brosens and Prof Quenby

Miscarriage is defined as the spontaneous loss of pregnancy before the baby reaches viability. Besides the physical trauma, miscarriage causes considerable anxiety, stress, and depression.

17 Jan 2013

Jersey Shore University Medical Center launches Meridian Executive Health program

Jersey Shore University Medical Center announces the launch of the Meridian Executive Health program, a health care pilot initiative designed for busy individuals whose schedule demands a streamlined but high quality experience.

17 Jan 2013

Women who have migraine with aura more likely to develop major cardiovascular events

Women who have migraines with aura, which are often visual disturbances such as flashing lights, may be more likely to have problems with their heart and blood vessels, and those on newer contraceptives may be at higher risk for blood clots, according to two studies released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.

17 Jan 2013

Polypill could reduce CVD and stroke in Latin Americans by up to 21% at lower cost

A single combination pill could reduce cardiovascular disease and stroke in Latin Americans by up to 21 percent at a cost of about $35 per quality adjusted life year gained, according to a study led by a University of Wisconsin School of Medicine and Public Health research team.

17 Jan 2013

American Association of Heart Failure Nurses, Milner-Fenwick announce partnership

Milner-Fenwick, a multi-media publisher for the healthcare community, and the American Association of Heart Failure Nurses (AAHFN) announced a partnership which includes the AAHFN's endorsement of Milner-Fenwick's Heart Failure Patient Education Video Series.

17 Jan 2013

State roundup: Maine hospitals fighting for timely Medicaid payments

New York police plan to distribute "bait bottles" of fake pain-killers equipped with invisible GPS devices in a drive to combat the scourge of pharmacy robberies by addicts and sellers looking for oxycodone tablets, which can fetch more than $80 per pill on the street.

17 Jan 2013

Boston Scientific initiates Blazer Open-Irrigated Catheter clinical trial in atrial fibrillation

The first patient has been treated in the Boston Scientific Corporation ZERO AF clinical trial to evaluate the safety and effectiveness of the Blazer Open-Irrigated Temperature Ablation Catheter in patients with symptomatic, drug refractory paroxysmal atrial fibrillation.

17 Jan 2013

People most often visit doctors because of skin issues, joint disorders and back pain

A new Mayo Clinic Proceedings study shows that people most often visit their health care providers because of skin issues, joint disorders and back pain. Findings may help researchers focus efforts to determine better ways to prevent and treat these conditions in large groups of people.

17 Jan 2013

Presence of trees can improve human health

Evidence is increasing from multiple scientific fields that exposure to the natural environment can improve human health. In a new study by the U.S. Forest Service, the presence of trees was associated with human health.

17 Jan 2013

FDA approves St. Jude Medical’s Merlin.net Patient Care Network

St. Jude Medical, Inc., a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval of the next-generation Merlin.net Patient Care Network (PCN), a secure, Internet-based remote care system for patients with implanted medical devices.

17 Jan 2013

Argon Medical to launch Cleaner15 technology for mechanical thrombectomy procedures

Furthering its commitment to advancing the treatment of patients diagnosed with ESRD (End Stage Renal Disease), Argon Medical Devices, Inc. takes another leap forward with the launch of the Cleaner15 Rotational Thrombectomy System.

17 Jan 2013

Top-line results from Amgen’s Aranesp Phase 3 trial on heart failure and anemia

Amgen today announced top-line results of the Phase 3 Aranesp (darbepoetin alfa) RED-HF (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial.

17 Jan 2013

Patients with COPD more likely to develop serious bacterial infections

It is well known that COPD patients run a higher risk of contracting respiratory infections. However, a new thesis from Lund University in Sweden shows that they are also at higher risk of other bacterial infections, such as tuberculosis (TB) and pneumococcal and staphylococcal infections that can cause serious illness.

16 Jan 2013

Heart Disease News and Research

Latest Heart Disease News and Research

Stroke patients with PTSD less likely to adhere to treatment regimens

nContact receives FDA clearance for EPi-Sense cardiac ablation device

Octapharma receives FDA approval for Octaplas to treat blood clotting disorders

Atrial fibrillation increases risk of kidney failure in people with CKD

Prevention opportunity for postoperative cardiac arrest

Dentate gyrus, fimbria volumes reduced in bipolar II disorder

Potential stem cell therapy for Duchenne’s

Miscarriage and molecular signals: an interview with Prof Brosens and Prof Quenby

Jersey Shore University Medical Center launches Meridian Executive Health program

Women who have migraine with aura more likely to develop major cardiovascular events

Polypill could reduce CVD and stroke in Latin Americans by up to 21% at lower cost

American Association of Heart Failure Nurses, Milner-Fenwick announce partnership

State roundup: Maine hospitals fighting for timely Medicaid payments

Boston Scientific initiates Blazer Open-Irrigated Catheter clinical trial in atrial fibrillation

People most often visit doctors because of skin issues, joint disorders and back pain

Presence of trees can improve human health

FDA approves St. Jude Medical’s Merlin.net Patient Care Network

Argon Medical to launch Cleaner15 technology for mechanical thrombectomy procedures

Top-line results from Amgen’s Aranesp Phase 3 trial on heart failure and anemia

Patients with COPD more likely to develop serious bacterial infections

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Heart Disease News and Research

Latest Heart Disease News and Research

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in